A Safety and Efficacy Study of Farletuzumab in Subjects With Adenocarcinoma of the Lung

This study is ongoing, but not recruiting participants.

Sponsor:

Information provided by (Responsible Party):

Morphotek

ClinicalTrials.gov Identifier:

NCT01218516

First received: October 7, 2010

Last updated: January 8, 2013

Last verified: January 2013

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study is ongoing, but not recruiting participants.
Estimated Study Completion Date:	January 2015
Estimated Primary Completion Date:	March 2013 (Final data collection date for primary outcome measure)